DarioHealth (DRIO) Projected to Post Earnings on Wednesday

DarioHealth (NASDAQ:DRIO) is expected to release its Q1 2025 earnings data before the market opens on Wednesday, May 14th. Analysts expect DarioHealth to post earnings of ($0.07) per share and revenue of $7.48 million for the quarter.

DarioHealth Price Performance

NASDAQ DRIO opened at $0.70 on Friday. DarioHealth has a 12-month low of $0.50 and a 12-month high of $1.93. The firm’s fifty day simple moving average is $0.68 and its two-hundred day simple moving average is $0.74. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $29.10 million, a P/E ratio of -0.74 and a beta of 1.55.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on DRIO shares. TD Cowen downgraded shares of DarioHealth from a “buy” rating to a “hold” rating and cut their price objective for the company from $2.00 to $1.00 in a report on Wednesday, January 29th. Stifel Nicolaus dropped their price objective on shares of DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, March 11th.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.